title: [Comparison of circadian variation of serum theophylline concentration and bioavailability between Theo-dur tablet and a new sustained-release theophylline formulation (E-0686 granule)].
authors.forename: M
authors.initials: M
authors.lastname: Kishida
authors.forename: M
authors.initials: M
authors.lastname: Okuma
authors.forename: T
authors.initials: T
authors.lastname: Uekusa
authors.forename: K
authors.initials: K
authors.lastname: Akimoto
authors.forename: T
authors.initials: T
authors.lastname: Obata
authors.forename: A
authors.initials: A
authors.lastname: Akazawa
authors.forename: Y
authors.initials: Y
authors.lastname: Odajima
authors.forename: T
authors.initials: T
authors.lastname: Nagakura
authors.forename: Y
authors.initials: Y
authors.lastname: Iikura
authors.forename: K
authors.initials: K
authors.lastname: Hukushima
mesh_terms: D001682:Biological Availability; D002648:Child; D002940:Circadian Rhythm; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008297:Male; D013607:Tablets; D013806:Theophylline / Q000008:administration & dosage / Q000097:blood*
chemical_list: D003692:Delayed-Action Preparations; D013607:Tablets; D013806:Theophylline